MLB Commissioner Bud Selig speaks during a news conference in New York

When it comes to drugs, Major League Baseball has learned nothing from the past, wishes to learn nothing in the future

95 Comments

I don’t know what Ryan Braun or Alex Rodriguez or Nelson Cruz or any of the other players thus far implicated in the Biogenesis mess has done. I don’t know what they’ve taken. I don’t know what they’ve said beyond their curt, lawyerly public statements. I don’t know if they’ve lied. But I know this much: any action Major League Baseball takes against them based on the cooperation of Anthony Bosch is equivalent to erecting a building on a rotten foundation. But of course, baseball has done this before, so it’s not all that surprising that they’ll attempt to do it again.

The lever Major League Baseball is using to get Bosch’s cooperation is a specious lawsuit.  I wrote about it at length when it was filed against Bosch back in March. The lawsuit is a transparent attempt to obtain documents as opposed to vindicate legal rights.Baseball has suffered no cognizable injury at law from Biogenesis. It has not been harmed financially nor has it had its reputation legally harmed in any way by this little clinic.

What it has done, however, is put the fear of God into the sleazy clinic owner at the center of it all. Bosch already faces professional ruination due to an investigation by the State of Florida. The MLB lawsuit, even if it never reached a conclusion, could mean financial ruination for him as well. He had no friends in the world and nowhere to turn. That is, until Bud Selig offered him a lifeline. “Sing for me, Tony, and your problems will largely disappear,” Bud is telling him.

And don’t think they won’t. This was Major League Baseball’s m.o. during the Mitchell Report. Drug dealers — actual felons, had they had the book thrown at them as they should have — got off with a slap on the wrist or nothing at all because Major League Baseball and, in the case of the Mitchell Report, a former United States Senator, went to bat for them with the government. In exchange they got dirt a-plenty. I presume the same arrangement is being constructed for Mr. Bosch as well.

Except the return baseball got for its past deals was pretty paltry, all things considered. Brian McNamee and Kirk Radomski sang for the Mitchell Report investigators. And the result was a partial list of PED users. The lowest hanging fruit. The stupid guys who wrote personal checks for illegal drugs and used dealers who were well known among Major League Baseball officials. While this all made for a big splash in late 2007, as time has gone on we have learned that the Mitchell Report barely scratched the surface of the problem. PED use remained widespread, other, smarter drug dealers continued to ply their trade. And the end game of the entire exercise — the criminal prosecutions of Barry Bonds and Roger Clemens — ended in abject failure.

It didn’t have to be that way. Major League Baseball was hell-bent on hanging a few big-name players out to dry. Major League Baseball decided that the most interesting and important thing about steroids in baseball was who used and who didn’t as opposed to what steroids meant, how they damaged the game and how they damaged its users.  It did that rather than asking the real questions about PEDs. The ones that would make a difference. Questions about PED habits. Players’ introduction to PEDs. Questions about their actual impact. Questions about the culture of drugs in baseball that could, hopefully, provide answers about how to stop it.

But these questions were never answered, never asked. Indeed, Major League Baseball has evinced a profound lack of curiosity about such topics.  A lack of curiosity that mirrored the blinkered approach to the matter the press and the game took in the 1990s. To the extent we know the answers to any of these questions the information is piecemeal and, without the imprimatur of Major League Baseball, unofficial, unacknowledged and not at all rigorously researched.

Baseball is doing this again. Getting into bed with a drug dealer who, allegedly, provided PEDs to dozens and possibly scores of players. Using his likely unreliable and clearly self-serving words to nab a few big names rather than to understand and address the problem they have in front of them. If Bud Selig cared a wit about what actually went on with Biogenesis he’d ignore Bosch completely, work with the union to get players on board with spilling their guts in exchange for amnesty or reduced discipline and end the process with a far more thorough accounting of what went on than they can ever expect from a cornered man looking to save his neck.

But then again, Major League Baseball has never seemed too interested in what actually went on with any of this in any thorough way. The Mitchell Report was certainly not meant to answer any questions. It was meant to stop them. To put a bookend on the p.r. disaster that Ken Caminiti and Jose Canseco uncorked in 2002. To put a bookend on the steroids era itself, really, and to allow fans, the press and the government to pretend that steroids use was limited to a certain unfortunate time and to certain unsavory group of people. Baseball is doing it again. It’s going to nip Biogenesis in the bud, hang a few big names out to dry and declare victory.

If, in fact, it actually achieves victory. Because the union is not going to simply sit back if Major League Baseball is going to attempt to level double-dip penalties against some of its highest profile players without a drug test or even a single reliable witness. Yes, “just cause” is a basis for discipline under the Joint Drug Agreement. But the words of a pressured, compromised and disgraced phony physician/criminal isn’t the stuff of “just cause” in most adversarial proceedings, baseball arbitrations included.

But no matter the outcome of all of that, in a few years, when the players who would cheat have learned all the lessons from Major League Baseball’s myopic approach to things, they’ll just deal with smarter dealers. Guys less susceptible to Major League Baseball’s squeeze play. And Baseball will have nothing other than an empty P.R. victory to show for itself. Nothing, because it never demonstrated a lick of curiosity about the problem itself beyond how it played in the papers.

Report: Cubs have offered prospect Gleyber Torres to the Yankees for Aroldis Chapman

NEW YORK, NY - JULY 17:  Aroldis Chapman #54 of the New York Yankees delivers a pitch in the ninth inning against the Boston Red Sox at Yankee Stadium on July 17, 2016 in the Bronx borough of New York City.  (Photo by Elsa/Getty Images)
Elsa/Getty Images
2 Comments

Rian Watt of Baseball Prospectus is hearing that a trade that would send Aroldis Chapman to the Cubs involves prospect Gleyber Torres and more going to the Yankees. He adds that the holdup in the trade talks is centered around a contract extension for Chapman, believed to be around four years in length and $60 million total. The deal may not be finalized if the Cubs don’t get him signed to an extension they like. In Watt’s words, “Package is set. Extension is not.”

We learned earlier on Sunday that the Yankees were working hard to trade Chapman, reportedly in contact with at least four teams. The Cubs were not believed to be the front runners but certainly upped the ante by offering Torres.

Torres, 19, is rated the Cubs’ #1 prospect and #24 overall in baseball by MLB Pipeline. The shortstop has spent the season with Single-A Myrtle Beach, batting .275/.359/.433 with nine home runs, 47 RBI, 62 runs scored, and 19 stolen bases in 409 plate appearances.

Torres is currently roadblocked at shortstop by Addison Russell, and 21-year-old Ian Happ is rated #3 in the Cubs’ system, so the club would be dealing from surplus.

Blue Jays designate Drew Storen for assignment

TORONTO, CANADA - MAY 29: Drew Storen #45 of the Toronto Blue Jays delivers a pitch in the eleventh inning during MLB game action against the Boston Red Sox on May 29, 2016 at Rogers Centre in Toronto, Ontario, Canada. (Photo by Tom Szczerbowski/Getty Images)
Tom Szczerbowski/Getty Images
1 Comment

Prior to Sunday afternoon’s game against the Mariners, the Blue Jays designated reliever Drew Storen for assignment and recalled reliever Ryan Tepera from Triple-A Buffalo.

Storen, 28, had a nightmare of a time with the Jays, leaving with a 6.21 ERA and a 32/10 K/BB ratio over 33 1/3 innings. The Jays acquired him in January from the Nationals in exchange for outfielder Ben Revere and a player to be named later.

Storen is owed the remainder of his $8.375 million salary, which makes it likelier that the right-hander will pass through waivers unclaimed. He’ll be eligible for free agency after the season.